Plasma bradykinin and early diabetic nephropathy lesions in type 1 diabetes mellitus.
<h4>Objective</h4>To examine the association of bradykinin and related peptides with the development of diabetic nephropathy lesions in 243 participants with type 1 diabetes (T1D) from the Renin-Angiotensin System Study who, at baseline, were normoalbuminuric, normotensive and had normal...
Main Authors: | Kevin M Wheelock, Jian Cai, Helen C Looker, Michael L Merchant, Robert G Nelson, Gudeta D Fufaa, E Jennifer Weil, Harold I Feldman, Ramachandran S Vasan, Paul L Kimmel, Brad H Rovin, Michael Mauer, Jon B Klein, CKD Biomarkers Consortium |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0180964 |
Similar Items
-
ACE-I and ARBs in early diabetic nephropathy
by: Michael Mauer, et al.
Published: (2002-12-01) -
Editorial: Association between diabetic nephropathy and diabetic retinopathy or non-diabetic nephropathy
by: Haiyong Chen, et al.
Published: (2024-01-01) -
Diabetic Nephropathy
by: Prasit Chanarat
Published: (2015-02-01) -
Diabetic nephropathy
by: Jordanova Elena, et al.
Published: (2018-01-01) -
Bradykinin and its role in osteoarthritis
by: L. De Falco, et al.
Published: (2013-07-01)